Sichuan Kelun Pharma...
SZSE:002422
¥ 34,00
¥-0,13 (-0,38%)
34,00 ¥
¥-0,13 (-0,38%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

¥1,00
Earnings Per Share
¥11,64
Revenue Per Share
47,24%
Gross Margin %
¥54,08 B
Market Cap
¥0,19 B
Long-Term Debt
Earnings Per Share
¥1,00
Revenue Per Share
¥11,64
Gross Margin %
47,24%
Market Cap
¥54,08 B
Long-Term Debt
¥0,19 B

Financials

Year Year 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2013 2012 2011 2010
EPS Earnings Per Share ¥1,07 ¥1,86 ¥1,59 ¥1,15 ¥0,78 ¥0,58 ¥0,65 ¥0,85 ¥0,52 ¥0,42 ¥0,45 ¥0,75 ¥0,76 ¥0,67 ¥0,51
Earnings Earnings ¥1,70B ¥2,96B ¥2,37B ¥1,62B ¥1,10B ¥829,50M ¥935,86M ¥1,22B ¥748,80M ¥565,25M ¥648,00M ¥1,08B ¥1,09B ¥964,80M ¥734,40M
RPS Revenue Per Share ¥11,64 ¥13,71 ¥14,41 ¥13,40 ¥12,29 ¥11,51 ¥12,25 ¥11,36 ¥7,94 ¥6,36 ¥5,39 ¥4,74 ¥0,00 ¥3,57 ¥2,80
Revenue Revenue ¥18,51B ¥21,81B ¥21,45B ¥18,91B ¥17,28B ¥16,46B ¥17,64B ¥16,35B ¥11,43B ¥8,57B ¥7,76B ¥6,83B ¥0,00M ¥5,15B ¥4,03B
OCF Operating Cash Flow ¥2,64B ¥4,49B ¥5,34B ¥3,13B ¥2,85B ¥2,22B ¥2,22B ¥2,95B ¥1,10B ¥1,73B ¥1,24B ¥1,05B ¥0,00M ¥342,93M ¥149,29M
FCF Free Cash Flow ¥0,00M ¥2,82B ¥1,37B ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M
OM Operating Margin 11,37% 18,54% 15,88% 11,96% 8,59% 9,33% 8,47% 11,18% 9,90% 11,62% 13,35% 21,29% 21,01% 20,87% 18,93%
GM % Gross Margin % 47,24% 51,35% 52,03% 52,27% 53,74% 53,96% 59,95% 59,16% 50,65% 42,40% 41,35% 44,59% 41,81% 42,02% 39,88%
FCFS Free Cash Flow Per Share ¥0,64 ¥1,78 ¥2,45 ¥1,59 ¥1,31 ¥0,70 ¥0,62 ¥1,14 ¥-0,26 ¥0,25 ¥-0,42 ¥-0,84 ¥-1,65 ¥-1,15 ¥-0,39
LT Debt Long-Term Debt ¥191,10M ¥342,00M ¥2,65B ¥4,70B ¥3,51B ¥5,10B ¥2,15B ¥5,45B ¥3,50B ¥1,39B ¥3,42B ¥4,42B ¥3,28B ¥232,72M ¥142,79M
Sha. Stocks 1.590,43M 1.590,78M 1.488,39M 1.411,53M 1.406,28M 1.430,18M 1.439,79M 1.439,85M 1.440M 1.345,84M 1.440M 1.440M 1.440M 1.440M 1.440M
×